SCHEMBL30567321

SCHEMBL30567321

CC(C)c1ccc(F)c(C(C)C)c1N

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.32
ANPEP P15144 1/20 0.30
DPP4 P27487 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6280677 1.00 PDE2A (0.32) PDE2AANPEPDPP4
SCHEMBL22012652 0.83 TSHR (0.36)
SCHEMBL19507077 0.83 TSHR (0.32)
SCHEMBL15082620 0.79 ANPEP (0.32) PDE2AANPEPDPP4
SCHEMBL6751624 0.77 LMNA (0.31)
SCHEMBL17190308 0.77 ANPEP (0.35) PDE2AANPEPDPP4
SCHEMBL19505690 0.76 POLB (0.34)
SCHEMBL22014779 0.76 LMNA (0.34) ANPEPDPP4
SCHEMBL9879909 0.75 GABRA1 (0.39)
SCHEMBL12678215 0.75 ACHE (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117209447-A Compounds and compositions for treating disorders associated with NLRP activity 诺华股份有限公司 2023-12-12 CN disclosed
CN-117143042-A Compounds and compositions for treating disorders associated with NLRP activity 诺华股份有限公司 2023-12-01 CN disclosed
CN-111094243-B Compounds and compositions for treating disorders associated with NLRP activity 诺华股份有限公司 2023-09-05 CN disclosed